- Correction
- Open access
- Published:
Correction: Progress of CCL20-CCR6 in the airways: a promising new therapeutic target
Journal of Inflammation volume 22, Article number: 2 (2025)
Correction to: Li et al. Journal of Inflammation (2024) 21:54
Following the publication of the Original Article, the authors reported that the order of references in Table 1 was not correctly modified during the typesetting.
The incorrect table is as follows:
The correct table is as follows:
The Original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12950-024-00427-5.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Li, Y.J., Geng, WL., Li, CC. et al. Correction: Progress of CCL20-CCR6 in the airways: a promising new therapeutic target. J Inflamm 22, 2 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12950-025-00428-y
Published:
DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12950-025-00428-y